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Summary
Nedd4 family interacting protein-1 (Ndfip1) is a protein
whose only known function is that it binds Nedd4,
a HECT-type E3 ubiquitin ligase. Here we show that
mice lacking Ndfip1 developed severe inflammation
of the skin and lung and died prematurely. This condi-
tion was due to a defect in Ndfip12/2 T cells. Ndfip12/2
T cells were activated, and they proliferated and adop-
ted a T helper 2 (Th2) phenotype more readily than did
their Ndfip1+/+ counterparts. This phenotype resem-
bled that of Itchymutant mice, suggesting that Ndfip1
might affect the function of Itch, an E3 ubiquitin ligase.
We show that T cell activation promoted both Ndfip1
expression and its association with Itch. In the ab-
sence of Ndfip1, JunB half-life was prolonged after T
cell activation. Thus, in the absence of Ndfip1, Itch is
inactive and JunB accumulates. As a result, T cells
produce Th2 cytokines and promote Th2-mediated
inflammatory disease.
Introduction
Ubiquitin was first discovered nearly 30 years ago as a
lymphocyte differentiation-promoting factor (Goldstein
et al., 1975). Since then, accumulating evidence sug-
gests that, among other functions, ubiquitin ligation is
used to regulate both innate and adaptive immune re-
sponses (Coscoy and Ganem, 2003; Heissmeyer et al.,
2004; Jeon et al., 2004; Liu et al., 2005; Uchida et al.,
2004). Although hundreds of proteins have been identi-
fied that act directly as enzymes in the ubiquitination pro-
cess, regulation of these proteins is not well understood.
Protein ubiquitination is a highly ordered process, the
net result of which is the covalent binding of one or more
ubiquitin moieties to a protein substrate (Liu, 2004).
*Correspondence: baoli-yang@uiowa.eduUbiquitin conjugation can have one of several conse-
quences for the protein, targeting it for degradation,
changing its subcellular location, or altering its activation
status. Among the proteins responsible for these com-
plex series of events, the E3 ubiquitin ligases are key in
determining which proteins are targeted. E3 ubiquitin li-
gases are classified into three families based on their
structures: the homology to the E6-associated protein
carboxyl terminus (HECT) domain-containing E3 ubiqui-
tin ligases (Huibregtse et al., 1995), the really interesting
new gene (RING) domain E3 ubiquitin ligases (Freemont,
2000), and the U-box E3 ubiquitin ligases (Hatakeyama
et al., 2001).
HECT-type E3 ubiquitin ligases have several shared
features. As their name implies, they all have HECT do-
mains that facilitate the transfer of ubiquitin to the sub-
strate (Huibregtse et al., 1995). Additionally, HECT-type
E3 ubiquitin ligases all have multiple WW domains that
mediate protein-protein interactions. WW domains
have been shown to bind proline-rich domains (Pirozzi
et al., 1997) and phosphoserine and phosphothreonine
residues (Lu et al., 1999; Staub et al., 1996; Sudol,
1996) and thus support a stable interaction with binding
partners.
The most well-characterized WW domain-containing
HECT-type E3 ubiquitin ligases are Nedd4-1 and
Nedd4-2. Nedd4-2 has been shown to regulate epithelial
Na+ channels in the kidney and other tissues (Abriel
et al., 2000; Dinudom et al., 1998; Harvey et al., 1999;
Staub et al., 1996, 1997). Nedd4-1 has been implicated
in lymphocyte function and tolerance (Heissmeyer
et al., 2004, 2005; Magnifico et al., 2003; Scharschmidt
et al., 2004). Because of their potential importance, sev-
eral groups have focused on identifying targets of
Nedd4 ubiquitin ligase activity. These studies used the
WW domains of either Nedd4-1 or Nedd4-2 to identify
associated proteins (Ingham et al., 2005; Jolliffe et al.,
2000; Kurakin and Bredesen, 2002; Murillas et al., 2002).
Nedd4 family interacting protein 1 (Ndfip1, N4WBP5)
was recently identified by one of these screens because
of its ability to bind the WW domains of Nedd4-1 (Jolliffe
et al., 2000). When overexpressed in COS cells, Ndfip1
was also shown to interact with the WW domains of other
HECT-type family members, including K1AA0332,
WWP2, AIP-4, and Itch (Harvey et al., 2002). Whether
and under what circumstances any of these proteins in-
teract in vivo is not known. Furthermore, the biologic out-
come of such interactions is also unknown except that
it leads to the ubiquitination of Ndfip1 (Harvey et al.,
2002). This observation might suggest that Ndfip1 is sim-
ply a target of Nedd4’s ubiquitination activity. However,
data from yeast suggest that Ndfip1 may have broader
effects on E3 ubiquitin ligase activities.
In yeast, the Ndfip1 ortholog Bsd2 acts as an adaptor,
linking the yeast Nedd4 ortholog Rsp5 to its substrates
(Hettema et al., 2004). In Bsd2 mutant strains, several
targets of Rsp5 were not properly degraded. This finding
led the authors to propose that Bsd2 plays an important
role in the recognition and removal of misfolded mem-
brane proteins by Rsp5 (Hettema et al., 2004).
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930Figure 1. The Generation of Mice Homozygous for a Disrupted Ndfip1 Gene
(A) The location of the gene trap vector within the Ndfip1 locus is shown. The Ndfip1 locus contains 8 exons spanning about 45 Kb of genomic
DNA.
(B) The gene trap vector was inserted into the second intron and results in the production of a truncated Ndfip1 mRNA that encodes exons 1
and 2.
(C) Offspring resulting from the intercross between Ndfip1+/2 mice were tested by PCR to identify Ndfip12/2 animals via the primer pairs shown
in Figure 1A.
(D) To confirm the disruption of Ndfip1, RNA was isolated from Ndfip1+/+ and Ndfip12/2 mice and RT-PCR was performed. We detect the pres-
ence of two transcripts in Ndfip12/2 tissues, Ndfip1-AST and Ex2-bGEO. GADPH is shown as a reverse transcriptase and loading control.To better understand the interaction between Ndfip1
and the HECT-type E3 ligases, we generated mice lack-
ing Ndfip1. Ndfip12/2 mice develop a severe inflamma-
tory disease at 6 weeks of age, and few animals survive
beyond 12 weeks of age. This phenotype is, at least in
part, due to a defect in T cells that, in vivo, results in their
spontaneous activation. Based on data we present here,
we propose that Ndfip1 binds Itch and promotes Itch
function. Association between Ndfip1 and Itch facili-
tates the degradation of a well-described Itch target,
JunB, and prevents JunB from driving T helper 2 (Th2)
cytokine production.Results
The Generation of Mice that Are Homozygous
for a Disrupted Ndfip1 Locus
ES cells harboring a disruption of the Ndfip1 gene were
obtained from BayGenomics (cell line code RRD002).
The targeted ES cells contain a gene-trapping vector
that was inserted within intron 2 of the gene encoding
Ndfip1 (Stryke et al., 2003). The gene trap vector is com-
posed of an artificial intron (En2), a splice acceptor
site, and a bGeo cassette (Figure 1A). This disruption
of the Ndfip1 gene results in a truncation of the mRNA
Ndfip1 Directs Itch to Control T Cell Activation
931Figure 2. Loss of Ndfip1 Leads to Inflammatory Disease, Splenomegally, Hepatomegally, and Extramedullary Hematopoiesis of the Spleen and
Liver
(A–D) H&E-stained tissue sections from 8-week-old Ndfip12/2 ear (A), liver (B and C), and spleen (D).
(E) PAS-stained sections of Ndfip12/2 lung.
(F) The number of live Ndfip12/2 and Ndfip1+/+ mice was measured over time.transcript just beyond exon 2 (Figure 1B). To confirm the
presence of the gene trap vector, ES cells were tested
by PCR. PCR with primers ‘‘a’’ and ‘‘b’’ (Figure 1A) pro-
duces the 1.0 kb bp band, indicating the presence of
the wild-type locus. In contrast, PCR with primers ‘‘a’’
and ‘‘c’’ yielded a band of 0.3 bp, indicating disruption
of the Ndfip1 locus. ES cells carrying this mutation
were injected into mouse blastocysts to generate chi-
meras as described previously (McDonald et al., 1999).
Two male chimeras transmitted to the germline. The re-
sulting agouti progeny were tested for the presence of
the disrupted Ndfip1 allele by PCR (data not shown).
Mice heterozygous for the disrupted locus were inter-
crossed to produce homozygous Ndfip12/2 animals.
The PCR protocol described above was used to geno-
type the resulting progeny (Figure 1C). Once identified,
homozygous mice were tested by RT-PCR to see
whether they expressed any full-length Ndfip1 mRNA
(Figure 1D). These data show that two kinds of tran-
scripts were produced in Ndfip12/2 tissues. One of
them (EX2-bGeo) was a truncated transcript that con-
sisted of exons 1 and 2 and bGeo. The second one
(Ndfip1-AST), based on mRNA sequencing, was an al-
ternatively spliced transcript consisting of the full-length
Ndfip1 with 206 bp from the ampicillin resistance gene
inserted in the reverse orientation between exons 2
and 3 (data not shown). The bGeo was not included in
this transcript. This Amp fragment introduced a transla-
tion stop site in each of the three possible reading
frames. Taken together, these data suggest that inser-
tion of the gene trap vector into the Ndfip1 locus results
in a disruption of the Ndfip1 gene.
Mice Lacking Ndfip1 Develop Spontaneous
Inflammation of the Skin and Die Prematurely
Ndfip12/2 mice appeared normal at birth. Furthermore,
the number of Ndfip12/2 mice produced from inter-
crosses of Ndfip1+/2 animals conformed, for the most
part, to normal Mendelian expectations (see Table S1
in the Supplemental Data available online). At 6 weeks,
Ndfip12/2 began to develop skin lesions on their ears
(data not shown), and by 8 weeks of age, all Ndfip12/2
mice had these lesions. Gross inspection of the mice re-
vealed a profound hepatomegally and splenomegally.Organ size was increased from a liver to body weight ra-
tio of 486 4 mg/g for Ndfip1+/+ animals to 1016 11 mg/
g for Ndfip12/2 mice (p < 0.008) and from a spleen to
body weight ratio of 3.4 6 0.5 mg/g for Ndfip1+/+ mice
to 16.96 2.7 mg/g for Ndfip12/2 animals (p < 0.003). Ad-
ditionally, over time, the tails of Ndfip12/2 became seg-
mented in appearance and tended to be shorter then the
tails of their Ndfip1+/+ littermates (data not shown).
In an effort to determine the underlying cause of the
increased spleen and liver size and inflammation of the
ear, tissue sections were examined. Hematoxylin and
eosin (H&E) staining of paraffin-embedded sections of
organs from Ndfip12/2 mice revealed multiple defects.
Ear sections revealed a high degree of inflammation
with a predominantly eosinophilic and lymphocytic infil-
trate (Figure 2A). The liver contained intrahepatic bile
ducts (Figure 2B). Apparent in both liver and spleen
were extensive foci of extramedullary hematopoiesis
(Figures 2C and 2D). Lungs of Ndfip12/2 mice also dis-
played signs of inflammation with goblet cell hyperpla-
sia and an inflammatory infiltrate in the perivascular
regions (Figure 2E). Kidneys in the Ndfip12/2 mice ap-
peared normal (data not shown).
Because the phenotype showed both an alteration in
hematopoiesis and was inflammatory in nature, we char-
acterized hematopoietic-derived cells of primary and
secondary lymphoid organs by flow cytometry. We
found that Ndfip12/2 mice had fewer B cells (B220+)
and more myeloid lineage cells (GR1+) in their bone mar-
row as compared to age-matched Ndfip1+/+ animals,
whereas pre-erythroid cells (ter119+) were equal in num-
ber (Figure S1A). The spleens of mice lacking Ndfip1 also
showed elevated numbers of myeloid lineage cells and,
in keeping with histological evidence of splenic hemato-
poiesis, pre-erythroid cells (Figure S1B). T cells in
Ndfip12/2 animals, particularly those that expressed
CD4, were increased in number and were activated as
shown by their increased expression of CD44.
Although some Ndfip12/2 mice died soon after wean-
ing, many of the mice survived longer (Figure 2F). The
persistent inflammation of the ear resulted in destruc-
tion of much of the ear tissue, and once inflammation
was established, mice began to appear cachectic. Be-
ginning at 10 weeks, there was a dramatic decrease in
Immunity
932Figure 3. Reconstitution of Wild-Type Mice with Ndfip12/2 Marrow Leads to Inflammatory Disease
C57BL6 mice were lethally irradiated and then reconstituted with Ndfip12/2 bone marrow cells. The resulting mice developed skin lesions be-
tween 6 and 8 weeks of age.
(A) The skin lesions showed an infiltration of inflammatory cells.
(B and C) Histological findings in spleen (B) and liver (C) were similar to those seen in Ndfip12/2 mice. a, inflammation; b, extramedullary
hematopoiesis.the survival of Ndfip12/2 mice, and none of these mice
survived beyond 14 weeks of age.
The Ndfip2/2 Inflammatory Phenotype Is Due to
a Defect in Cells of the Hematopoietic Lineage
Flow cytometric analysis revealed multiple changes in
cells from the hematopoietic lineage; however, these
changes either could have been due to a primary defect
caused by the loss of Ndfip1 or could have been caused
by inflammation. To find out whether Ndfip1 deficiency
causes a defect in bone marrow-derived cells that initi-
ates inflammation, we transferredNdfip12/2 orNdfip1+/+
bone marrow cells into lethally irradiated C57BL/6 recip-
ients and monitored the mice for signs of inflammation.
Mice receiving Ndfip12/2 cells, but not those that
were reconstituted with Ndfip1+/+ cells, developed skin
lesions beginning approximately 5 weeks postreconsti-
tution and, like Ndfip12/2 mice, died within 8 weeks of
the onset of inflammation. Recipients of Ndfip12/2
bone marrow cells also developed splenomegaly and
hepatomegaly (data not shown). Again, the inflamma-
tory infiltrate in the skin was predominantly lymphocytic
and eosinophilic (Figure 3A), and extramedullary hema-
topoiesis was observed in the enlarged spleen and liver
(Figures 3B and 3C). However, some of the characteris-
tics of the Ndfip12/2 mice were less severe or not reca-
pitulated in the bone marrow chimeras. Splenomegally
and hepatomegally was less pronounced in the chi-
meras, and the reconstituted mice did not develop a seg-
mented tail (data not shown) or intrahepatic bile ducts
(Figure 3C). Thus, nonhematopoietic cells are required
for these phenotypes in the Ndfip12/2 mice.
However, these data show that bone marrow-derived
cells are responsible for the inflammatory disease and
premature deaths observed in Ndfip12/2 mice.
T Cells Lacking Ndfip1 Are Increased in Number
and Are Activated
To find out which bone marrow-derived cells were re-
sponsible for promoting inflammation in the Ndfip12/2
mice, we reconstituted lethally irradiated mice with
a mixture of equal numbers of GFP+ (Schaefer et al.,
2001b) Ndfip1+/+ and GFP2 Ndfip12/2 bone marrow.
This experimental design allowed study of Ndfip1+/+
and Ndfip12/2 cells exposed to the same inflammatory
conditions. Additionally, this experiment allowed us to
distinguish between primary events (which would occuronly in the Ndfip12/2 cells) and secondary events (which
would affect both Ndfip12/2 and Ndfip1+/+ cells).
Mice reconstituted with Ndfip12/2 bone marrow de-
veloped disease approximately 6 weeks after bone mar-
row transfer (see above), and therefore we chose to
analyze the mixed chimeras between 5 and 6 weeks
after reconstitution. This time frame allowed us to see
changes in immune system cells that preceded any out-
ward signs of inflammation. Because GFP expression in
the Ndfip1+/+ cells limited the fluorimeter channels avail-
able to characterize the cells, we sorted live GFP+ and
live GFP2 cells from each tissue and stained cells with
the various antibodies, including some that would regis-
ter in the same channel as GFP. We then treated each
sample with saponin, thereby releasing all of the GFP
from the cells, which allowed us to detect antibody
staining that would otherwise be obscured.
With this technique, data were collected from six mice,
and in each case, Ndfip1+/+ cells were compared to
Ndfip12/2 cells isolated from the same mouse. The per-
centages of the Ndfip1+/+ and Ndfip12/2 cells in the thy-
muses and bone marrow of the mixed chimeras were
similar (Figures 4A and 4B). Likewise, in the spleens of
the chimeras, the numbers of macrophages (CD11b+),
a subset of dendritic cells (CD11b+ and CD11c+), and B
cells of both origins were comparable and there was
no evidence that B cells of either type were abnormally
activated, as tested by expression of CD69 (Figure 4C).
However, a greater percentage of the Ndfip12/2 cells in
spleens (and lymph nodes, data not shown) were T cells
(15.5% 6 3% of Ndfip12/2 cells versus 9.2% 6 1.8% of
Ndfip1+/+ cells). In addition, many more of the Ndfip12/2
cells were activated, as defined by increased expression
of CD44 and Ly6c (data not shown). This difference was
true for both CD4+ and CD8+ T cells (Figures 4D and 4E).
Thus, T cells lacking Ndfip1 were activated prior to any
outward signs of inflammation.
To ensure that the T cell defects were not due to differ-
ences in the genetic background between the Ndfip12/2
(C57BL/6 and 129.ola) and GFP Tg. mice (C57BL/6), we
compared these mixed chimeras to those made with
a mixture of cells from GFP Tg. mice and Ndfip1+/2
mice. The Ndfip1+/2 mice have a mixed genetic back-
ground that is similar to that of theNdfip12/2mice. Com-
parison of these two sets of mixed chimeras revealed
that the T cell defect was a direct consequence of loss
of Ndfip1 (Figure S2).
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C57BL/6 mice were lethally irradiated and reconstituted with a mixture of equal numbers ofNdfip12/2 andNdfip1+/+ (GFP-expressing) bone mar-
row. Primary and secondary lymphoid organs of the resulting mice were analyzed 5–6 weeks after the bone marrow transfer. Cells were sorted
based on whether or not they expressed GFP, stained, and then treated with saponin to allow release of GFP from the cells.
(A) Cells were isolated from the thymus and stained for CD4 and CD8 single-positive populations.
(B) Cells from the bone marrow were stained for B cell markers (B220 and IgM) or myeloid markers (GR1).
(C) Cells were isolated from the spleen and stained for B cell (B220), dendritic cell (CD11b and CD11c), or myeloid (GR1 and F4/80) markers or for
markers indicating activation (CD69).
(D) Spleen cells were stained for T cell-specific markers (CD4 and CD8) or markers indicating activation status (CD62L and CD44).
(E) The percent of activated cells among the different populations in both the spleen and lymph nodes were quantified. Open bars represent
Ndfip1+/+ T cells, whereas the black bars representNdfip12/2 T cells. Error bars depict standard errors (n = 8). Both CD4+ and CD8+ T cells lacking
Ndfip1 were significantly more likely to show an activated phenotype. *p < 0.05; **p < 0.01 (paired t test).Based on these data, we could not rule out the possi-
bility that cells other then T cells are affected by the loss
of Ndfip1. However, our data clearly indicate that T cells
lacking Ndfip1 are activated before any outward signs of
disease and that this activation is intrinsic to the mutant
T cell.
Ndfip12/2 T Cells Proliferate More and Readily
Produce IL-4 In Vitro
Inflammatory disorders of the skin, particularly those
with eosinophilic involvement, are often potentiated by
Th2 CD4+ T cells (Del Prete, 1992; Ricci et al., 1994; Ro-
magnani et al., 1991). Accordingly, we tested whether
Ndfip12/2 T cells were capable of responding effectively
to TCR-mediated signals that lead to proliferation and/
or the production of the Th2 cytokine, IL-4, or the Th1 cy-
tokine, IFN-g. We again used T cells isolated from mixed
chimera mice to ensure that the T cells were exposed to
the same environment prior to analysis. T cells from themixed chimeras were sorted for GFP expression, la-
beled with CFSE, and cultured for 3 days in the presence
or absence of the TCR-stimulating reagents, anti-CD3
and anti-CD28. We then stained cells with antibodies
against CD4 and CD8 and treated the cells with saponin
to remove GFP.
Unstimulated cells did not divide regardless of Ndfip1
expression, demonstrating thatNdfip12/2 cells were still
dependent on TCR stimulation to divide. On the other
hand, when cells were stimulated, Ndfip12/2 CD4+ T
cells proliferated more readily than wild-type cells (Fig-
ure 5A). These data imply that Ndfip1 might affect how
T cells respond to activation signals.
We then wanted to see whetherNdfip12/2 T cells were
capable of producing cytokines after culture in Th1 or
Th2-polarizing conditions. T cells were isolated from
the spleens of 5- to 6-week-old Ndfip1+/+ and Ndfip12/2
mice, and activated T cells (CD44+) were depleted from
each sample. Cells were then cultured for 6 days under
Immunity
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(A) Spleen cells from mixed chimeras, 5–6 weeks posttransfer, were sorted based on GFP expression, labeled with CFSE, and stimulated with
anti-CD3 (plate-bound) and anti-CD28, or left unstimulated. After 3 days, cells were stained, treated with saponin, and analyzed for loss of CFSE.
(B) Spleen and lymph node cells from 5- to 6-week-old Ndfip12/2 and Ndfip1+/+ mice were isolated and depleted of CD44+ cells and CD8+ cells.
Cells were then stimulated with anti-CD3 and anti-CD28 or stimulated in the presence of Th1 or Th2 differentiating conditions. The percentages
represent cytokine-producing cells as a percent of the total CD4+ cells. Data compiled from three independent experiments show that the per-
cent of IL-4 producers averaged 39.8% 6 5.5% for Ndfip1+/+ and 72.9% 6 8.1% for Ndfip12/2 T cells; p < 0.04 paired Student’s t test. IFN-g
production was not statistically different between the two genotypes.either Th1- or Th2-polarizing conditions or activated in
the absence of cytokine polarization.
When cells were activated in the absence of polarizing
conditions (control), neither type of cell produced much
IL-4 or IFN-g (Figure 5B). Furthermore, when cells were
cultured under Th1-polarizing conditions, Ndfip12/2 T
cells were no more likely to produce IFN-g than control
cells. In contrast, when cells were cultured in Th2-polar-
izing conditions, Ndfip12/2 T cells were much more
likely to make IL-4. These data support the hypothesis
that loss of Ndfip1 biases T cells toward a Th2 pheno-
type and might help to explain why mice lacking Ndfip1
are prone to develop an inflammatory condition with
high numbers of infiltrating eosinophils.Ndfip12/2 T Cells Are Much More Likely to Drive
a Th2 Response In Vivo
The presence of eosinophils at the inflammatory sites
suggests that Ndfip12/2 mice develop a Th2-mediated
disease. Knowing that loss of Ndfip1 led to a defect in
T cells suggested to us that these T cells might drive dis-
ease because of an uncontrolled bias toward production
of Th2 cytokines. Thus, we wished to test whether
Ndfip12/2 T cells were Th2 biased in vivo and whether
this bias resulted in increased Th2-dependent immuno-
globulin switching.
For this experiment, we made bone marrow chimera
mice to study a large number of animals that were
healthy at the time of immunization. We immunized the
Ndfip1 Directs Itch to Control T Cell Activation
935Figure 6. Immunization of Ndfip12/2 Mice with OVA+CFA or OVA+ALUM Leads to IL-4 Production and Increased Antigen-Specific IgE
Ndfip1+/+ and Ndfip12/2 bone marrow chimeras were immunized with OVA+CFA or OVA+ALUM 5 weeks after reconstitution.
(A) 8 days later, cells were isolated from spleens and lymph nodes and cultured in media alone or in the presence of OVA peptide (OVA323-339).
Effector CD4+ T cells (CD4+, CD44hi, CD62Llo) were then analyzed for intracellular IL-4 or IFN-g.
(B) Sera were collected from the mice 8 days after immunization and analyzed for total and OVA-specific immunoglobulin levels by ELISA. Each
circle represents the percent of (A) CD44+ T cells producing cytokine or (B) the Ig amounts from an individual mouse. Open circles indicate that
the chimera was Ndfip1+/+, whereas closed circles represent Ndfip12/2 chimeras.mice with ovalbumin (OVA) mixed with an adjuvant that
induces either a Th2-polarized response (Alum) or a
Th1-polarized response (complete Freund’s adjuvant,
CFA). Mice reconstituted with Ndfip12/2 bone marrow
typically began to show signs of inflammation 6 weeks
after the transfer of bone marrow, and their condition
worsened over the next 4–6 weeks. We found that
when these same mice were immunized with Alum 5
weeks after reconstitution, they became very sick within
8 days such that the experiment had to be terminated
prematurely. Chimeras made from Ndfip1+/+ bone mar-
row remained healthy even after they were immunized
with OVA + Alum and they showed no signs of inflamma-
tion in either their skin or lung (Figures S2A and S2B). In
contrast, chimeras made from Ndfip12/2 bone marrow
that received OVA + Alum had visible lesions on their
skin (data not shown) and inflammation in the skin and
lungs (Figures S2C and S2D).
T cells from all groups were analyzed 8 days after anti-
gen stimulation for cytokine production. Very few T cells
from Ndfip1+/+ bone marrow chimeras made IL-4 in re-
sponse to in vitro challenge with antigen (Figure 6A).This was true regardless of the adjuvant used and is
probably due to the short duration of the experiment. In
contrast, the Ndfip1+/+ cells were able to produce IFN-g
in response to ex vivo antigen exposure but only if they
had come from animals immunized with OVA + CFA, in
line with the known Th1-polarizing capacity of this adju-
vant. In contrast to these results, T cells lacking Ndfip1
were consistently less likely to produce IFN-g as com-
pared to wild-type cells and instead produced IL-4.
This was true regardless of the adjuvant used to prime
the animal and occurred even in the absence of antigen
challenge in vitro.
To find out whether the Th2 bias of Ndfip12/2 T cells
were reflected in the antibody isotypes generated in
mice containing these cells, we measured the amounts
of various immunoglobulin isotypes in unimmunized chi-
meras and the isotypes of ovalbumin antibodies in the
immunized animals (Figure 6B). In comparison with
Ndfip1+/+ chimeras, Ndfip12/2 chimeras contained high
amounts of the Th2-dependent immunoglobulin class
IgE and low amounts of the Th1-dependent isotypes
IgG2a/b. Similar results were observed for ovalbumin
Immunity
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Alum, with amounts of IgE higher, and levels of IgG2a/b
and IgG3 lower in the Ndfip12/2 chimeras than the
Ndfip1+/+ mice.
These results support the conclusion that lack of
Ndfip1 predisposes T cells toward a Th2 phenotype, re-
gardlessof theconditionsunder which theyareactivated.
Ndfip1 Binds Itch after T Cell Stimulation
and Promotes Itch Function
The phenotype of the Ndfip12/2 mice is reminiscent of
that described for the Itchy mice that lack functional
Itch protein (Hustad et al., 1995; Perry et al., 1998). It
has been shown that Itch ubiquitinates Jun proteins
(Gallagher et al., 2006; Gao et al., 2004) and Jun protein
amounts are increased in Itchy animals (Fang et al.,
2002). Jun proteins promote IL-4 synthesis (Hartenstein
et al., 2002; Li et al., 1999) and thus could cause T cells to
become Th2 biased.
Given thatNdfip12/2 and Itch mutant mice have a sim-
ilar phenotype and because a WW domain portion of
Itch has been shown to bind Ndfip1 in vitro (Harvey
et al., 2002), we postulated that Ndfip1 might regulate
Itch. To test this idea, we first needed to know whether
Ndfip1 protein is expressed in T cells and whether its
expression affects Itch expression.
T cells were isolated from 6- to 8-week-old Ndfip+/+
and Ndfip12/2 mice, the cells were cultured in media or
stimulated for 24 hr, and their whole-cell lysates were an-
alyzed by immunoblot for expression of Itch and Ndfip1.
Ndfip1+/+ and Ndfip12/2 T cells contained equivalent
amounts of Itch, indicating that expression of Ndfip1
does not regulate Itch expression in T cells.
Unstimulated T cells expressed negligible amounts of
Ndfip1 protein. After 2 hr of stimulation, Ndfip1 protein
increased in amount (Figure 7A), suggesting that Ndfip1
function may be particularly relevant in activated T cells.
To find out whether Ndfip1 could physically associate
with Itch, we immunoprecipitated Itch from lysates of T
cells that were unstimulated or stimulated for 24 hr. We
found that isolates of Itch contained Ndfip1 in stimulated
T cells (Figure 7B). This was specific for the Itch IP and
did not occur in isotype controls (Figure S4); thus,
Ndfip1 does bind Itch in activated T cells.
To determine whether these interactions could occur
after lysis, we chose to look at whether the proteins co-
localized in activated T cells. Itch and Ndfip1 localization
was examined in unstimulated T cells or in cells that had
been stimulated for 2 or 24 hr. In unstimulated cells,
Ndfip1 was not expressed, and Itch was found in intra-
cellular vesicles (Figure 7C). 2 hr after stimulation,
Ndfip1 could be detected and was localized near the
plasma membrane. Because we did not see staining
with this antibody in nonpermeabilized cells (data not
shown), we believe this region to represent cytoplasm
near the plasma membrane. At this time point, some of
the Itch colocalized near the plasma membrane with
Ndfip1. Colocalization of Itch with Ndfip1 was more ev-
ident by 24 hr when nearly all the Itch and Ndfip1 polar-
ized into a region near the inner surface of the cell. Inter-
estingly, in cells lacking Ndfip1, Itch remained localized
within the cytoplasmic vesicles for the duration of this
experiment. This would suggest that Ndfip1 is required
to recruit Itch to a discrete region within the cell.That Itch and Ndfip1 are physically associated after T
cell stimulation supports the hypothesis that Ndfip1
might promote Itch function. One well-described func-
tion of Itch is ubiquitination of JunB, a phenomenon
that leads to degradation of the protein. JunB expression
is increased 1–2 hr after T cell stimulation and then wanes
(Foletta et al., 1998). This timing is consistent with ex-
pression of Ndfip1 and its colocalization with Itch. There-
fore, we postulated that Ndfip1 might promote Itch-
dependent degradation of JunB. This would predict
that JunB could have a longer half-life in cells lacking
Ndfip1.
To test this idea, JunB expression was measured in
unstimulated T cells, in T cells that had been stimulated
for 2 or 6 hr, and in T cells that had been stimulated for 6
hr, but incubated in cyclohexamide for the last 4 of these
6 hr, to block protein synthesis. As predicted by previ-
ous reports, JunB amounts increased after 2 hr of stim-
ulation, and this was also true in cells lacking Ndfip1
(Figure 7D, compare lanes 1 and 2). Amounts of JunB
subsequently declined in Ndfip1+/+ cells (Figure 7D),
but this decline did not occur in cells lacking Ndfip1.
The maintenance of JunB in Ndfip12/2 cells was mainly
due to lack of JunB degradation, rather than increased
synthesis of the protein because amounts of JunB re-
mained high in these cells even if the cells were cultured
in cyclohexamide. Thus, Ndfip1 controls amounts of
JunB in activated T cells by inducing its degradation,
probably via association of Ndfip1 with Itch.
To determine whether the reduced JunB degradation
was a direct result of the loss of Ndfip1 rather than a by-
product of the activation status of the cells, we retrovir-
ally re-expressed Ndfip1 in an Ndfip12/2 T cell line. As
was the case in primary T cells that lack Ndfip1, cells
from an Ndfip12/2 T cell line that were transduced with
an empty vector showed prolonged JunB expression
after stimulation (Figure 7E, top left). In contrast, cells
transduced with an Ndfip1-containing vector degraded
JunB to the same extent as did Ndfip1+/+ cells.
We also wanted to know whether increasing Ndfip1 in
wild-type cells would alter their JunB degradation. To do
this, we overexpressed Ndfip1 in an Ndfip1+/+ T cell line,
again via the retroviral system. Like primary T cells, cells
from the Ndfip1+/+ cell line transduced with an empty
vector show degradation of JunB 6 hr after stimulation
(Figure 7E, bottom left). When Ndfip1 expression was in-
creased in these cells, by expressing a Flag-tagged
Ndfip1, JunB expression was reduced. Cells that ex-
pressed the Flag-tagged Ndfip1 contained less JunB
protein 2 hr after stimulation when compared to empty
vector controls. 6 hr after stimulation, JunB expression
had returned to prestimulation amounts in cells overex-
pressing Ndfip1, while their wild-type counterparts con-
tinued to express elevated amounts of JunB.
These data predict that JunB expression might be un-
usually high in T cells from mice lacking Ndfip1. To test
this, we isolated T cells from 8- to 10-week-oldNdfip1+/+
andNdfip12/2mice and tested their cell lysates for JunB
by immunoblot. JunB expression was increased in T
cells lacking Ndfip1 (Figure 7F). These amounts were
quantified in several different experiments, normalized
to b-actin, and compared to Ndfip1+/+ T cells (normaliz-
ing wild-type to 1). We found that Ndfip12/2 T cells con-
tained approximately 5-fold more JunB than wild-type
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937Figure 7. Ndfip1 Interacts with Itch and Promotes Degradation of JunB
(A) T cells were isolated from the spleens and lymph nodes of Ndfip1+/+ and Ndfip12/2 mice and cultured in media alone or stimulated 24 hr with
anti-CD3 and anti-CD28. Cell lysates were immunoblotted with antibodies against Itch, Ndfip1, or b-actin.
(B) Ndfip1+/+ and Ndfip12/2 T cells were lysed directly after isolation (U) or cultured in the presence of anti-CD3 and anti-CD28 (S). Lysates were
immunoprecipitated with an anti-Itch antibody and blots were probed for Itch and Ndfip1.
(C) Ndfip1+/+ and Ndfip12/2 T cells were stimulated for the times points indicated and then fixed, permeabilized, and stained for intracellular Itch
and Ndfip1.
(D) Ndfip1+/+ and Ndfip12/2 T cells were isolated and depleted for CD44+ cells. Cells were then cultured in media alone or stimulated for 2 or 6 hr
or stimulated for 6 hr with cyclohexamide added for the last 4 hr of stimulation. Numbers represent JunB amounts normalized to unstimulated
controls for each genotype. Degradation of JunB is measured by comparing lane 4 versus lane 2 for each genotype.
(E) Ndfip12/2 and Ndfip1+/+ T cell lines were transduced with the empty MIG retrovirus (MMLV-IRES-eGFP) or a Flag-tagged Ndfip1 containing
MIG retrovirus. GFP+ cells were sorted and JunB degradation was analyzed as described in (D).
(F) T cells were directly isolated from an 8- to 10-week-old Ndfip1+/+ and Ndfip12/2 mice and WCL were analyzed for JunB protein amounts.
b-actin is shown as a control for protein loading. LC, light chain.cells; it is possible, however, that some of the increased
JunB in these cells results from their increased activa-
tion status. Taken together, these data support our hy-
pothesis that the loss of Ndfip1 results in reduced deg-
radation of JunB, likely the result of reduced Itch
function.
Discussion
Ndfip1 was recently described to be a novel membrane-
associated protein whose only known function was that
it binds to, and is ubiquitinated by, Nedd4 (Harvey et al.,
2002). The data we present here reveal that Ndfip1 plays
a prominent role in T cell function and prevents sponta-
neous inflammation. This is illustrated by the fact that
Ndfip12/2 mice have an inflammatory disease charac-
terized by skin lesions that resemble the human condi-
tion known as atopic dermatitis. T cells from Ndfip12/2mice are increased in number and appear activated prior
to the onset of disease. This phenotype is directly attrib-
utable to the loss of Ndfip1 expression in T cells, be-
cause wild-type T cells within the same mouse are
much less likely to display an activated phenotype.
Therefore, in wild-type T cells, Ndfip1 acts to control
T cell activity and thus prevent inflammation and Th2-
mediated disease.
The phenotype we observed in Ndfip12/2 mice was
nearly identical to that described for Itchy mutant
mice, suggesting that Ndfip1 and Itch might interact.
Two independent lines of evidence, colocalization of
Ndfip1 and Itch and coimmunoprecipitation of Ndfip1
with Itch, supported this hypothesis.
Itch has been implicated in the management of T cell
tolerance. Itch has been shown to regulate the response
of committed Th2 cells (Venuprasad et al., 2006). Addi-
tionally, Itch expression is induced in anergic T cells
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checkpoints in newly activated T cells. Furthermore,
the E3 ligase activity of Itch increases after T cell activa-
tion, a process that requires the serine/threonine kinase
JNK (Gao et al., 2004). JNK phosphorylates Jun proteins
and also phosphorylates Itch. Phosphorylated Itch then
causes the ubiqutination of JunB. In the absence of Itch,
JunB builds up in T cells, contributing to their Th2 bias
(Fang et al., 2002; Gao et al., 2004). Here we show that,
in the absence of Ndfip1, JunB half life is lengthened
and the amount of JunB increases, suggesting that
Ndfip1 is needed for Itch to catalyze ubiqutination and
turnover of the protein. Our data suggest that Ndfip1
might cause relocalization of Itch in a manner that facil-
itates this interaction. Thus, whether Ndfip1 promotes
ubiquitination by bringing Itch together with its target
proteins, or enhances Itch activity in another way, has
yet to be determined. It seems likely that Ndfip1 could
affect the ubiquitination of Itch targets other than
JunB. Furthermore, in addition to Itch, Ndfip1 may alter
the function of other HECT-type E3 ligases, particularly
those of the Nedd4 family, thus contributing to the acute
onset of disease in Ndfip12/2 mice.
Based on these data, we propose a novel control
mechanism for Itch activation, in which T cell stimulation
increases Ndfip1 expression, thereby allowing Ndfip1 to
bind Itch and promote Itch function, ultimately resulting
in JunB degradation. This process could act to suspend
the T cell in a state of active quiescence, in which pro-
teins required for effector function and cytokine secre-
tion are actively produced but degraded and the cell
awaits further instruction.
Experimental Procedures
Gene-Targeted ES Cells
The ES cell line with a disrupted Ndfip1 gene (RRD002) was obtained
from BayGenomics. The gene-trapping vector that caused the dis-
ruption was inserted within intron 2 according the sequences ob-
tained from 50 RACE (Stryke et al., 2003). The ES cells were injected
into mouse blastocysts to generate chimeras as described previ-
ously (McDonald et al., 1999). Five chimeras, four males and one
female, were generated and germline transmission was obtained
from two of the male chimeras.
Genotyping of Mice
Intron 2 of the mouse Ndfip1 gene is about 5 Kb long. A common re-
verse primer against the artificial intron (En2) within the gene-trap-
ping vector, 50 GTT GCA CCA CAG ATG AAA CG 30, and five forward
primers (equally distributed within the intron) were designed and
used for amplification to determine the site of vector insertion within
this intron. Upon identification of the insertion site, other primers
were used for genotyping. The following two primers amplified
a 466 bp fragment from the insertional allele of Ndfip1: forward, 50
TAG GCC AAG GTG AAA ACT GG 30; and reverse, 50 AGT GCG
GTA CCA GAC TCT CC 30. The same forward primer paired with
the following reverse primer amplified a 1010 bp fragment from the
wild-type allele: 50 AGA GGT GGG TTC AAC AGT GG 30.
RT-PCR
Total RNA was isolated from liver, spleen, kidney, heart, thymus, and
lymph nodes of both wild-type and knockout mice with Tri-Reagent
(Sigma Chemical Company, St. Louis, MO) according to the manu-
facturer’s instructions. Three sets of primers were designed to iden-
tify the presence of different parts of the transcript, the upstream
(exons 1 and 2) and downstream (exons 4 and 7) coding regions,
and the coding region across the insertion site (exons 2 and 3):
Ndfip1Ex1f, 50 GCC CGA TCA GCT CTC TCG 30, and Ndfip1Ex2r,
50 CAG GCT CCT CTT CAT TCT GC 30, amplify 134 bp fragmentfrom cDNA; Ndfip1Ex2f, 50 ATG CTC CTC CAC CAT ACA GC 30,
and Ndfip1Ex3r, 50 GGA ACC AAA GGG ATC GTA GC 30, amplify
166 bp fragment from cDNA; Ndfip1Ex5f, 50 CCA GCT GAG GAT
AGG AAA CG 30, and Ndfip1Ex7r, 50 GGC ATC TTC CGA ACT TTT
GC 30, amplify 294 bp fragment from cDNA.
Mice
Ubi-GFP mice have been previously described (Schaefer et al.,
2001b). C57BL/6 and mice were purchased from The Jackson Lab-
oratory. All mice were maintained in a specific pathogen-free (SPF)
barrier facility. Care of the mice used in the experiments met the
standards set forth by the National Institutes of Health in their guide-
lines for the care and use of experimental animals.
T Cell Isolation, Cell Culture, Stimulation, and JunB Degradation
For most experiments, T cells were isolated from lymph nodes and/
or spleen by nylon wool. To make cell lines, we cultured cells, alter-
nating every 4 days between stimulating conditions (25 mg/ml plate-
bound anti-CD3 and 25 mg/ml anti-CD28) and resting conditions (20
ng/ml IL-2) for two rounds and then maintaining the cells in IL-2. To
measure JunB degradation, we stimulated cells as described above
for 2 or 6 hr or we stimulated cells for 2 hr, added 20 mg/ml cyclohex-
amide to block protein synthesis, and then continued stimulation for
the remaining 4 hr.
T Cell Polarization and Cytokine Staining
For in vitro polarization, T cells were cultured in either Th1-polarizing
media (10% FCS, 25 mg/ml plate-bound anti-CD3, 25 mg/ml plate-
bound anti-CD28, 1:50 dilution of IL-2 conditioned media, 5 ng/ml
IL-12, 3 mg/ml anti-IL4) or Th2-polarizing media (10% FCS, 25 mg/
ml plate-bound anti-CD3, 25 mg/ml plate-bound anti-CD28, 1:50 di-
lution of IL-2 conditioned media, 5 ng/ml IL-4, 5 mg/ml anti-IFN-g)
for 7 days. The cells were then washed and incubated for 4 hr with
25 mg/ml plate-bound anti-CD3 and anti-CD28 and media containing
Brefeldin A. The cells were surface stained with anti-CD4 antibody
diluted in 2.4G2 conditioned supernatant to block Fc receptors.
Cells were washed, fixed, and permeabilized according to manufac-
turer’s instructions (Cytofix/Cytoperm Plus Kit, BD Biosciences) and
incubated with anti-IL-4 and anti-IFNg antibodies for 1 hr at room
temperature. Data were acquired on a FACScalibur and analyzed
by CellQuestPro (Beckton Dickenson). To polarize cells in vivo,
mice were immunized with 100 mg OVA + either 2 mg Alum or 7 mg
CFA subcutaneously in the hind leg. 8 days after immunization,
spleen were taken and single-cell suspensions prepared. Spleno-
cytes were activated with OVA323-339 peptide at either 10 or 100
mg/ml or in the absence of peptide. 72 hr later, Brefeldin A was added
to the cultures and cells were then incubated for a further 6 hr. The
cells were then harvested, washed, incubated with 2.4G2 condi-
tioned supernatant and stained with anti-CD4-APC-Cy7, CD44-
Alexa 488, and CD62L-APC for 15 min. Cells were washed, fixed,
and permeabilized and then stained with anti-IL-4-PE or anti-IFNg-
PE as above. Data were acquired on a CYAN (Cytomation) and ana-
lyzed by FlowJO (Treestar).
Antibodies, Antibody Production, and Flow Cytometry
Cells were isolated and then incubated with various combinations of
the following antibodies diluted in 2.4G2 (anti-FcRg antibody) con-
taining media. Antibodies used were purchased from BD Biosci-
ences with the following exceptions: F4/80 (Serotec), TCRb
(Ham597) (McCormack et al., 1994). Flow cytometry was performed
on a FACScalibur instrument (Beckton Dickenson) or a Cyan (Cyto-
mation), and samples were analyzed with CellQuestPro software
(Beckton Dickenson) or by FlowJo (Treestar). The Ndfip1 antibody
(12-22) was made by immunizing hamsters with a synthetic peptide
corresponding to the N-terminal portion of Ndfip1 (VEPACGSG
YQQLQNEEPGE) coupled to KLH. After boosting, sera were col-
lected and tested in an ELISA by means of the Ndfip1-NTP coupled
to ovalbumin. Antibody-producing hybridomas were made as previ-
ously described (Pullen et al., 1988), and their specificity was tested
by western blot (Figure 7) and ELISA.
Itch Immunoprecipitation and Western Blotting
Cells were washed once in cold phosphate-buffered saline, lysed
with 500 ml cold immunoprecipitation buffer (50 mM Tris [pH 7.5],
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93910% glycerol, 1% Nonidet-P40, 137 mM NaCl, 10 mg/ml leupeptin,
10 mg/ml aprotinin, 1 mM PMSF, 2 mM NaF, 1 mM Na3VO4), and
then centrifuged at 15,000 rpm for 10 min.
Protein was quantified with a micro BCA kit and the lysates were
precleared with protein-A Sepharose beads for 30 min at 4C. Ly-
sates were immunoprecipitated with Itch antibody (BD Biosciences)
and protein-A Sepharose beads for 2 hr at 4C. Beads were washed
and then boiled in Laemmli sample buffer containing 20 mM DTT for
5 min at 100C. Samples were subjected to SDS-PAGE and trans-
ferred to nitrocellulose. Membranes were blocked with 5% milk in
Tris-buffered saline (20 mM Tris [pH 7.5], 137 mM NaCl) with
0.5%(v/v) Tween 20 (TTBS) for 1 hr at room temperature. Mem-
branes were then immunoblotted with anti-Itch (BD Biosciences),
anti-Jun B (Santa-Cruz), anti-Ndfip (described above), or anti-Ubiq-
uitin (Cell Signaling). Secondary antibodies were horseradish perox-
idase linked, and the detecting reagent was ECL.
Mixed Bone Marrow Chimeras and Cell Sorting
Bone marrow was flushed from the femurs of the various mice, and
the red blood cells (RBC) were lysed with buffered ammonium chlo-
ride. Cells were washed once and resuspended in PBS. Recipient
mice were lethally irradiated with either a single dose of 1000 rads
or a split dose of 800 and 400 rads, and 1–2 hr later, mice received
an equal mix of Ndfip1+/+ (Ubi-GFP) and Ndfip12/2 cells or
Ndfip1+/2 and a total of 53 106 bone marrow cells by tail vein injec-
tion. To prepare cells for analysis, spleen and lymph node cells were
isolated and sorted for live, GFP+ or live, GFP2 cells. Cells were sur-
face stained and then permeabilized with 0.1% saponin to release
GFP prior to flow cytometry analysis.
Retroviral Expression of Vectors
Ndfip1 cDNA was amplified from a Ndfip1-containing vector (ATCC)
by PCR via a forward primer 50 GCG CAG ATC TAT GCC TTG GCG
TTG GCG GCG CTG G 30 and a reverse primer 50 GCG CAG ATC
TAA TAA ATA AAG AGA ACT CTG GTC C 30. A Bgl II site was intro-
duced within each primer (underlined), and the Bgl II fragment in-
cluding Ndfip1 was subcloned into expression vector pCMV-Tag1
(Stratagene). Sequencing confirmed that this fused an in-frame
FLAG epitope tag to the N-terminal of the Ndfip1 protein. This
Flag-tagged Ndfip1 was subsequently subcloned into pMIG
(MMLV-IRES-eGFP) (Schaefer et al., 2001a). Ecotropic Phoenix cells
were transduced (lipofectamine, Invitrogen) with either empty pMIG
or the Flag-tagged Ndfip1-containing vector and pCL-Eco.Ndfip1+/+
and Ndfip12/2 cell lines were transduced by spinfection (Schaefer
et al., 2001a). GFP+ cells were sorted and tested for Flag expression
(Figure 7E).
Supplemental Data
Supplemental Data include four figures and one table and can be
found with this article online at http://www.immunity.com/cgi/
content/full/25/6/929/DC1/.
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